CDKN1A and mantle cell lymphoma: Subsequent study has been demonstrated that ARV-771 can also suppress proliferation of mantle cell lymphoma cells via increasing the levels of tumor suppressors, including CDKN1A/p21, HEXIM1, and NOXA (Sun et al., 2018).